Клинические аспекты применения симвастатина в комплексной терапии ишемического инсульта

Малыгин Александр Юрьевич, Хохлов Александр Леонидович · The Bulletin of Contemporary Clinical Medicine · 2012

The efficacy of simvastatin (40 mg/day) therapy initiated in acute stage of ischemic stroke was evaluated in 12-month comparative randomized study. Simvastatin 40 mg/day prescribed along with neuroprotective and antihypertensive treatment in acute stage of ischemic stroke leads to lowering of recurrent cardiovascular events number, positive dynamics of neurological status, regression of endothelial dysfunction, associated with improved renal function.

Cited by 0 works.

Authors